Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

28.54

0.00 (0.00%)

At close: Oct 03, 2025, 3:59 PM

28.54

0.00%

After-hours: Oct 03, 2025, 04:10 PM EDT

0.00% (1D)

Bid	26.03
Market Cap	1.04B
Revenue (ttm)	720K
Net Income (ttm)	-88.31M
EPS (ttm)	1.29
PE Ratio (ttm)	22.12
Forward PE	-7.28
Analyst	Buy
Dividends	n/a

Ask	30.5
Volume	217,702
Avg. Volume (20D)	770,703.2
Open	28.71
Previous Close	28.54
Day's Range	28.03 - 29.18
52-Week Range	6.43 - 42.27
Beta	1.71
Ex-Dividend Date	n/a

About RAPP

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RAPP

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RAPP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 weeks ago

-20.09%

Rapport Therapeutics shares are trading lower afte... Unlock content with Pro Subscription

3 weeks ago

-10.93%

Rapport Therapeutics shares are trading lower after the company announced a $250 million public offering.

News

2 weeks ago · seekingalpha.com

Rapport Therapeutics, Inc. (RAPP) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Transcript

Rapport Therapeutics, Inc. (NASDAQ:RAPP ) TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 17, 2025 11:20 AM EDT Company Participants Abraham Ceesay - CEO, Preside...

3 weeks ago · zacks.com

RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal

Rapport Therapeutics stock jumps 62% in a week as mid-stage study of RAP-219 meets goals in drug-resistant epilepsy patients.

3 weeks ago · invezz.com

Rapport stock plunges 18% on Wednesday: what went wrong after 200% rally

Rapport stock (NASDAQ: RAPP) cratered 18% on Wednesday as the market delivered a harsh verdict on its latest funding strategy. The catalyst was as predictable as it was painful.